RESUMO
Health care that addresses the emotional regulation capacity of patients with schizophrenia confronted with daily stress may contribute to a less anxious life. A psycho-physiological training [cardiac coherence training (CCT)] focusing on emotion regulation is known to decrease anxiety for healthy individuals. We performed a pilot cross sectional survey to explore the benefits of CCT for clinically stable patients with schizophrenia. Ten patients were enrolled in the program consisting of twelve weekly 1-h session programs monitored over a 2-month period. Standardised questionnaires were used before and after the intervention to assess anxiety, well-being outcomes, and how patients deal with stress and stressors. Results showed that this quite-well accepted intervention improved (or tended to improve) well-being outcomes, state-anxiety, and emotional stressors evaluation. The successful transformations were higher for patients with the highest clinical and emotional suffering. Thus, this pilot study revealed that CCT may help patients with schizophrenia to deal with anxiety in daily life.
Assuntos
Ansiedade/terapia , Biorretroalimentação Psicológica/métodos , Emoções/fisiologia , Frequência Cardíaca/fisiologia , Interocepção/fisiologia , Qualidade de Vida/psicologia , Esquizofrenia/terapia , Estresse Psicológico/terapia , Adulto , Ansiedade/epidemiologia , Comorbidade , Estudos Transversais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Esquizofrenia/epidemiologia , Estresse Psicológico/epidemiologia , Resultado do TratamentoRESUMO
INTRODUCTION: Behavioural therapies have been developed on the basis of Pavlov's and Skinner's learning theories. They have recently benefited from advances in the understanding of information handling and the organisation of perceptions of experience. It is for these two reasons that these treatments are called cognitive behaviour therapies (CBT). They have now achieved an important role in the treatment of addictions including tobacco smoking. Currently CBT's are seen as promising because they rely on cognitive restructuring combined with learning of new behaviour while following a process appropriate to the changing dynamic of the smoker. BACKGROUND: They have recently been recognised as of grade A effectiveness by the French Institute of Medical Research and may be recommended to all smokers whose primary intention is to stop. The establishment of a collaborative rapport and a therapeutic attitude are essential. They may be used during the three stages of cessation: preparation, stopping, and the prevention of relapse. A personalised functional analysis provides the patient with a management program using behavioural and, above all, cognitive techniques. The ideal is to combine a pharmacological and an optimised cognitive-behavioural approach. VIEWPOINT: The management of smoking patients has advanced with the understanding of a very complex problem, often associated with anxiety-depressive co-morbidities and other addictions. Tobacco specialists, psychiatrists, cognitive-behavioural therapists and addiction therapists must work together in the future, particularly in respect of research protocols. CONCLUSIONS: Cognitive-behavioural therapy is a useful technique in the personalisation and optimisation of management of the patient, particularly in the prevention of relapse. However, the evaluation of CBT is difficult methodologically and there are few studies evaluating CBT alone. On the other hand, CBT is effective, particularly where there are anxiety or depressive co-morbidities or other addictions that are found more and more frequently during consultations for tobacco smoking.
Assuntos
Terapia Cognitivo-Comportamental , Abandono do Hábito de Fumar/métodos , Fumar/terapia , HumanosRESUMO
The aim of the study was to compare control subjects and consultant patients with the SCID II (interview and questionnaire), then to compare clinical diagnosis with the SCID II (interview and questionnaire). The preliminary study was carried out to assess the feasibility of the procedure. This appraisal was conducted with a group of patients (n = 26) and a control group (n = 16). Only the patients were diagnosed according to DSM IV criteria. The patients and the control group completed the Mini-Mult and the SCID II (questionnaire and interview). The two groups were matched on sex, age and educational level. The two groups were discriminated on all Mini-Mult scales but one: the internalization index. The results showed that the SCID questionnaire and the SCID interview differentiate the two groups. The SCID questionnaire showed high sensitivity in the group of patients. It is a more efficient instrument to screen control subjects except one personality disorder (obsessive-compulsive). The diagnostic agreement between the clinical diagnosis and the structured interview was poor. However our results are comparable to the other studies.
Assuntos
Transtornos da Personalidade/diagnóstico , Escalas de Graduação Psiquiátrica , Adulto , Feminino , Humanos , Masculino , Testes Neuropsicológicos , Transtornos da Personalidade/epidemiologia , Prevalência , Reprodutibilidade dos TestesRESUMO
BACKGROUND: The goal of the present study was to validate the French version of the Agoraphobic Cognitions Questionnaire (ACQ). METHODS: Subjects consisted of 115 patients with panic disorder and agoraphobia, 54 obsessive-compulsive patients and 72 normal controls. Patients were referred for outpatient treatment. They filled in the questionnaire before and after entering treatment. The control group consisted of people taken from the general population. It was matched with the clinical groups on age, sex and education. RESULTS: The ACQ appears to have a constant factor structure across US, Dutch and French samples. Results support the validity of the total score of the ACQ. Patients with panic disorder and agoraphobia scored significantly higher than obsessive-compulsive patients and control subjects. On the ACQ physical concerns subscale agoraphobic patients were significantly different from obsessive-compulsive patients and control subjects. On the social/behavioural subscale agoraphobic patients and obsessive-compulsive patients were significantly different from control subjects. The French translation of the ACQ was found to be stable over an interval of 15 days in the control group. The Cronbach coefficients of both subscales were also satisfactory. These results support the stability and the internal consistency of the questionnaire. In addition, the French translation of the ACQ was sensitive to changes with cognitive-behavioural therapy. CONCLUSIONS: These results support the findings of Chambless and Gracely [Cogn Ther Res 1989;13:9-20]. The ACQ physical concerns subscale is a specific feature for the anxiety status experienced by patients with panic disorder and agoraphobia. The ACQ social/behavioural subscale seems to be a more general feature of anxious patients.
Assuntos
Agorafobia/diagnóstico , Psicometria/normas , Inquéritos e Questionários/normas , Pensamento/classificação , Adulto , Agorafobia/complicações , Agorafobia/psicologia , Agorafobia/terapia , Análise de Variância , Estudos de Casos e Controles , Análise Fatorial , Feminino , Humanos , Masculino , Transtorno Obsessivo-Compulsivo/diagnóstico , Transtorno Obsessivo-Compulsivo/psicologia , Avaliação de Resultados em Cuidados de Saúde/métodos , Transtorno de Pânico/complicações , Transtorno de Pânico/terapia , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , TraduçõesRESUMO
BACKGROUND: This multicentre study compared a 16-week buspirone treatment with placebo in patients presenting with panic disorder with agoraphobia and also receiving cognitive behaviour therapy (CBT). METHOD: Double-blind testing was maintained until week 68, but not tested; 91 patients were included; 14 placebo-responders excluded; 77 patients randomised; 48 reached week 16 and 41 reached week 68. RESULTS: At week 16, within-group analysis showed significant improvements in agoraphobia, panic attacks, and depression in both groups. Generalised anxiety improved only in CBT+buspirone. Between-group comparisons showed buspirone to have an effect on generalised anxiety and agoraphobia. Changes in degree of agoraphobia and depression were correlated in subjects on CBT+buspirone only. A significantly higher proportion of women, and of subjects showing high avoidance dropped out. Positive expectations regarding medication predicted success in both groups. At week 68, improvement was retained without significant buspirone effect. CONCLUSION: Buspirone enhanced the effects of cognitive behaviour therapy on generalised anxiety and agoraphobia in the short term.